L82-G17

CAS No. 92285-87-5

L82-G17 ( —— )

Catalog No. M28986 CAS No. 92285-87-5

L82-G17 is an uncompetitive LigI-selective inhibitor in human cells with utility as a probe of the catalytic activity and cellular functions of LigI.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 110 Get Quote
10MG 178 Get Quote
25MG 410 Get Quote
50MG 605 Get Quote
100MG 860 Get Quote
500MG 1728 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    L82-G17
  • Note
    Research use only, not for human use.
  • Brief Description
    L82-G17 is an uncompetitive LigI-selective inhibitor in human cells with utility as a probe of the catalytic activity and cellular functions of LigI.
  • Description
    L82-G17 is an uncompetitive LigI-selective inhibitor in human cells with utility as a probe of the catalytic activity and cellular functions of LigI.
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA/RNA Synthesis
  • Recptor
    FGFR2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    92285-87-5
  • Formula Weight
    264.7
  • Molecular Formula
    C11H9ClN4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC1=CC=CC(\C=N\NC2=C(Cl)C(=O)NN=C2)=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lescarbeau, Andre, et al. Preparation of substituted pyrrolopyrimidines as FGFR inhibitors and methods of making and using the same. WO2022109577.
molnova catalog
related products
  • T2AA

    T2AA is an inhibitor of proliferating cell nuclear antigen (PCNA) with IC50 of 1 μM for PCNA/PIP-box peptide interaction.

  • Myricetrin

    Myricitrin, a flavonoid compound isolated from the root bark of Myrica cerifera, exerts antinociceptive effects.

  • Puromycin dihydrochl...

    Puromycin 2hydrochloride is an aminonucleoside antibiotic, which acts as a protein synthesis inhibitor.